Neurocrine Biosciences, Inc <NBIX.O>: Truist Securities Raises Target Price to $200 From $155
NBIX•Related News
Karman Holdings Inc <KRMN.N>: Citigroup raises target price to $78 from $76
KRMN•
Oric Pharmaceuticals, Inc. <ORIC.O>: H.C. Wainwright raises target price to $27 from $25
ORIC•
AirSculpt Q2 revenue falls more than expected
AIRS•
Barrick falls on Q2 profit miss
B•
Agentix net loss narrows to $117,674 in Q1 FY27
AGTX•